Vectors for gene therapy
Schneider, H.
Medizinische Monatsschrift für Pharmazeuten 20(4): 98-102
1997
ISSN/ISBN: 0342-9601 PMID: 9198726 Document Number: 482647
Document emailed within 1 workday
Related Documents
Sandoval Rodríguez, A.S.; Salazar Montes, A.M.ía.; Armendáriz-Borunda, J. 2005: Viral vectors in gene therapy. Advantages of the adenoassociated vectors Revista de Gastroenterologia de Mexico 70(2): 192-202Chao, H.; Walsh, C.E. 2004: AAV vectors for hemophilia B gene therapy Mount Sinai Journal of Medicine new York 71(5): 305-313
Wilson, J.M. 1997: Vectors--shuttle vehicles for gene therapy Clinical and Experimental Immunology 107(Suppl 1): 31-32
Strayer, D.S.; Zern, M.A.; Chowdhury, J.R. 2002: What can SV40-derived vectors do for gene therapy? Current Opinion in Molecular Therapeutics 4(4): 313-323
Romero, E.L.; Morilla, M.J.; Bakas, L.S. 2001: Lipid vectors. new strategies for gene therapy Medicina 61(2): 205-214
Kondo, K. 2006: Application of human herpesvirus (HHV)-6 and HHV-7 to the gene therapy vectors Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 518-522
Connelly, S. 1999: Adenoviral vectors for liver-directed gene therapy Current Opinion in Molecular Therapeutics 1(5): 565-572
Latchman, D.S. 1999: Gene therapy with herpes simplex virus vectors Archivum Immunologiae et Therapiae Experimentalis 47(6): 335-340
Silman, N.J.; Fooks, A.R. 2000: Biophysical targeting of adenovirus vectors for gene therapy Current Opinion in Molecular Therapeutics 2(5): 524-531
Ichikawa, T.; Saeki, Y.; Tamiya, T.; Chiocca, E.A.; Ohmoto, T. 2000: Herpes simplex type-1 virus-based vectors for gene therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 58(4): 822-827
Parker, A.L.; Nicklin, S.A.; Baker, A.H. 2008: Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications Current Opinion in Molecular Therapeutics 10(5): 439-448
Małecki, M.; Swoboda, P.ł; Pachecka, J. 2009: Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy Acta Poloniae Pharmaceutica 66(1): 93-99
Yang, S.; Li, J-li.; Bi, H-chang.; Zhou, S-ning.; Liu, X-man.; Zeng, H.; Hu, B-fang.; Huang, M. 2016: Construction and function identification of luciferase reporter gene vectors containing SNPs in NFKBIA gene 3'UTR Yao Xue Xue Bao 51(1): 80-85
Choulika, A.; Nicolas, J.F. 1996: SLTR, a new family of retroviral vectors for gene transduction Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 190(1): 153-158
Aoyama, C.; Woltjen, K.; Mansergh, F.C.; Ishidate, K.; Rancourt, D.E. 2002: Bacteriophage gene targeting vectors generated by transplacement Biotechniques 33(4): 806
Miller, A.D.; Rosman, G.J. 1989: Improved retroviral vectors for gene transfer and expression Biotechniques 7(9): 980
Weecharangsan, W.; Opanasopit, P.; Lee, R.J. 2007: In vitro gene transfer using cationic vectors, electroporation and their combination Anticancer Research 27(1a): 309-313
Lattime, E.C.; Lee, S.S.; Eisenlohr, L.C.; Mastrangelo, M.J. 1996: In situ cytokine gene transfection using vaccinia virus vectors Seminars in Oncology 23(1): 88-100
Altschmied, J.; Duschl, J. 1997: Set of optimized luciferase reporter gene plasmids compatible with widely used CAT vectors Biotechniques 23(3): 436-438
Shen, Y-Yuan.; Gao, Z-Gao.; Rapoport, N. 2009: Recent advances in the applications of ultrasonic microbubbles as gene or drug vectors Yao Xue Xue Bao 44(9): 961-966